Infusion of chimeric antigen receptor T cells against dual targets of CD19 and B-cell maturation antigen for the treatment of refractory multiple myeloma

OBJECTIVE: To investigate the safety and efficacy of chimeric antigen receptor T (CAR-T) cell infusion in patients with refractory multiple myeloma (MM). METHODS: Sixteen patients diagnosed with refractory MM were included in this study. Patients received initial infusions of T-derived CD19/B-cell m...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Fang, Lu, Yin, Ge, Yongqin, Shang, Jingjing, Zhu, Xiaming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114292/
https://www.ncbi.nlm.nih.gov/pubmed/31939323
http://dx.doi.org/10.1177/0300060519893496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114292/
https://www.ncbi.nlm.nih.gov/pubmed/31939323
http://dx.doi.org/10.1177/0300060519893496

Ejemplares similares